Table 5.
≤2 cm (n = 59) | All tumours (n = 193) | |||||
---|---|---|---|---|---|---|
PFS | PFS | All-cause mortality | ||||
HR | P | HR | P | HR | P | |
Age | 1.020 | 0.426 | 1.005 | 0.546 | 1.038 | 0.006* |
Female gender | 0.381 | 0.012* | 0.584 | 0.01* | 0.893 | 0.701 |
Resection > 2010 | 0.629 | 0.167 | 0.727 | 0.185 | 0.421 | 0.015* |
Diameter | 1.121 | 0.111 | 1.012 | <0.001* | 1.005 | 0.268 |
Benign features | 0.723 | 0.231 | 0.327 | <0.001* | 0.733 | 0.404 |
Vascular invasion | 2.095 | 0.213 | 2.097 | 0.001** | ns | |
N1 | 2.87 | 0.051 | 1.669 | 0.02* | 1.447 | 0.234 |
LNR <0.2 vs >0.2 | ns | 0.816 | 0.686 | 0.565 | 0.141 | |
Metastasis | 2.968 | 0.072 | 2.991 | <0.001*** | 2.198 | 0.009* |
Extrahepatic | 10.797 | 0.001** | 0.378 | 0.001** | 4.231 | <0.001*** |
Stage vs IV | ||||||
I | 0.255 | 0.045* | 0.176 | <0.001*** | 0.425 | 0.087 |
II | 0.901 | 0.906 | 0.348 | <0.001*** | 0.562 | 0.135 |
III | 0.396 | 0.234 | 0.407 | <0.001*** | 0.402 | 0.018* |
Grade vs G3 | ||||||
G1 | 0.329 | 0.04* | 0.276 | <0.001*** | 0.121 | <0.001*** |
G2 | No G3 | 0.568 | 0.068 | 0.274 | <0.001*** | |
R1/R2 Margin | 1.382 | 0.678 | 2.312 | 0.001** | 1.104 | 0.803 |
*P < 0.05; **P < 0.005; ***P < 0.001.
HR, hazard ratio; LNR, lymph node ratio; PFS, progression-free survival.